| ¿µ¹® | platelet | ÇÑ±Û | Ç÷¼ÒÆÇ |
|---|---|---|---|
| ¼³¸í | °ñ¼öÀÇ °Å´ë ¼¼Æ÷ÀÎ °Å´ëÇÙ¼¼Æ÷ÀÇ ¼¼Æ÷Áú ÀϺΰ¡ ¶³¾îÁ®¼ ¼øÈ¯ Ç÷¾× Áß¿¡ ÃâÇöÇÑ °ÍÀ¸·Î Á÷°æÀÌ 2~4¥ìmÀÇ ÀÛÀº °ú¸³Ã¼ÀÌ´Ù. Ç÷¼ÒÆÇÀº ¼Õ»óÀ» ÀÔÀº Ç÷°üÀÇ ³ëÃâµÈ °áÇÕ Á¶Á÷¿¡ ºÙ¾î ¿©·¯ ¹°ÁúÀ» ºÐºñÇÏ¿© ÁöÇ÷ ¹× Ç÷¾× ÀÀ°í¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. |
||
| ¿µ¹® | Golgi body | ÇÑ±Û | °ñÁöü |
|---|---|---|---|
| ¼³¸í | ¼¼Æ÷³»ÀÇ ¼¼Æ÷Áú ¼Ò±â°ü. °ñÁöÀåÄ¡¶ó°íµµ ÇÑ´Ù. 1898³â ÀÌÅ»¸®¾ÆÀÇ C. °ñÁö¿¡ ÀÇÇØ ¿Ã»©¹ÌÀÇ ½Å°æ¼¼Æ÷ü¿¡¼ ¹ß°ßµÇ¾úÀ¸¸ç, ÀÌÈÄ ´Ù¸¥ ¼¼Æ÷¿¡¼, ¶Ç ±Ù·¡¿¡´Â ½Ä¹°¼¼Æ÷¿¡¼µµ ¹ß°ßµÇ°í ÀÖ´Ù. ÀüÀÚ Çö¹Ì°æ¿¡ ÀÇÇÑ ¿¬±¸¿¡¼ °ñÁöü¿¡ ÇØ´çµÇ´Â ºÎºÐÀº Ãþ»ó±¸Á¶-²Ê¸®±¸Á¶-¾Ë°»ÀÌ ±¸Á¶ÀÇ ¼¼°¡Áö·Î µÇ¾î ÀÖÀ¸¸ç, À̰ÍÀ» °ñÁö¿ªÀ̶ó ÇÑ´Ù. ±× ÀÛ¿ëÀº ¸íÈ®ÇÏÁö´Â ¾ÊÀ¸³ª »ù¼¼Æ÷ÀÇ ¼ÒÆ÷ü¿¡¼ ÇÕ¼ºµÈ ºÐºñ¹°ÀÌ °ñÁö¿ª¿¡¼ ³óÃàµÇ¾î ºÐºñ°ú¸³ÀÌ µÇ°í, ±× °ú¸³ÀÇ ¿ÜÃø¿¡ ¸·ÀÌ Çü¼ºµÈ´Ù°í »ý°¢µÇ°í ÀÖ´Ù. °ñÁöü´Â ¸·±¸Á¶¸¦ ÁÖ·Î Çϱ⠶§¹®¿¡ ÀÎÁöÁú°ú ´Ü¹éÁúÀ» ¸¹ÀÌ °¡Áö¸ç ¾ËÄ®¸®¼º Æ÷½ºÆÄŸ¾ÆÁ¦-ºñŸ¹Î C-Ä«·Îƾ µîÀ» ÇÔÀ¯ÇÑ´Ù. |
||
| ¿µ¹® | basal body temperature | ÇÑ±Û | ±âÃÊü¿Â |
|---|---|---|---|
| ¼³¸í | À½½Ä-¿îµ¿-Á¤½Å°¨µ¿ µî ü¿Â¿¡ ¿µÇâÀ» ÁÙ ¸¸ÇÑ ¿©·¯ Á¶°ÇÀ» ÇÇÇÏ¿© ¸ö°ú ¸¶À½ÀÌ ¾ÈÁ¤µÇ¾úÀ» ¶§ Àé ü¿Â, º¸Åë ¾ÆÄ§¿¡ ´«À» ¶á Á÷ÈÄ¿¡ Àç¸ç, ¿©¼ºÀÇ °æ¿ì ¿ù°æ Áֱ⿡ µû¶ó ´Þ¶óÁö¹Ç·Î ¼öÅ Á¶ÀýÀ̳ª ÀÚ±Ã, ³¼ÒÀÇ º´ Áø´Ü¿¡ ÀÀ¿ëÇÑ´Ù. 6~8½Ã°£ÀÇ ¾ÈÁ¤µÈ ¼ö¸éÀ» ÃëÇÑ ÈÄ ¾ÆÄ§ ÀÏÂï ±ú¾î³ª, ÀáÀÚ¸®¿¡¼ ³ª¿À±â Àü¿¡ ü¿Â°è¸¦ ÀÔ¿¡ ¹°¾î¼ ÃøÁ¤ÇÑ´Ù. ¹Ì¹¦ÇÑ Ã¼¿ÂÀÇ Â÷À̸¦ ÃøÁ¤ÇÏ´Â °ÍÀ̹ǷΠ¿©¼ºÃ¼¿Â°è¸¦ »ç¿ëÇÏ´Â °ÍÀÌ ÁÁ´Ù. ÀÌ ¿©¼ºÃ¼¿Â°èÀÇ ¼öÀº±¸ºÎ¸¦ ÇôÀÇ ¾Æ·§¸é¿¡ ³¢¿ì°í¼ ÀÔÀ» °¡º±°Ô ´Ù¹°°í ¾à 5ºÐ µ¿¾È ÀÖ´Ù°¡ ÃøÁ¤ÇÏ¸é µÈ´Ù. Á¤»óÀûÀÎ ±âÃÊü¿ÂÀº º¹ÀâÇÑ ¼ºÁÖ±âÀÇ º¯È¸¦ º¸À̱⠶§¹®¿¡ ¿ù°æÁֱ⿡ °üÇÑ °¢Á¾ Áø´ÜÀ» ºñ·ÔÇÏ¿© ÀÓ½Å-À¯»ê-ÀÌ»óÀÓ½ÅÀÇ Áø´Ü°ú ¼öÅÂÁ¶Àý µî¿¡ ÀÀ¿ëÇÏ´Â µî ¿©·¯ °¡Áö È¿°úÀûÀÎ ÀÚ·á°¡ µÈ´Ù. |
||
| ¿µ¹® | planes of body | ÇÑ±Û | ÀÎüÀÇ ¸é |
|---|---|---|---|
| ¼³¸í | ÀÎü¸¦ ¿©·¯ °³·Î ³ª´©´Â ¸éÀÌ Àִµ¥, Å©°Ô ½Ã»ó¸é(sagittal plane), °ü»ó¸é(coronal plane), ¼öÆò¸é(horizontal plane)À¸·Î ³ª´ ¼ö ÀÖ´Ù. ½Ã»ó¸éÀº ÀÎü¸¦ Á¿ì·Î, °ü»ó¸éÀº ¾ÕµÚ·Î, ¼öÆò¸éÀº À§¾Æ·¡·Î °¡¸£´Â ¸éÀÌ´Ù. |
||
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
|---|---|
| DB | data base; date of birth; deep breath; dense body; dextran blue; diabetes, diabetic; diagonal band; ... |
| EDB | early dry breakfast; electron-dense body; extensor digitorum brevis |
| IB | idiopathic blepharospasm; immune body; inclusion body; index of body build; infectious bronchitis; I... |
| LB | lamellar body; large bowel; left breast; left bronchus; left bundle; left buttock; leiomyoblastoma; ... |
| dcv | Dense core-vesicles |
|---|---|
| DNAPL | dense non-aqueous phase liquid |
| EDD | Electron dense deposits |
| LDCV | Large dense core vesicles |
| LDV | Large dense core vesicles |
| pericanicular dense bodies | <cell biology> Electron dense membrane bounded cytoplasmic organelles found near the canaliculi in liver cells: lysosomes. (18 Nov 1997) |
|---|---|
| subplasmalemmal dense zone | An electron-dense, 10-15 nm thick layer of highly cross-linked protein on the cytoplasmic surface of the cell membrane of epidermal corneocytes; it is highly resistant to proteolytic agents. Synonym: subplasmalemmal dense zone. (05 Mar 2000) |
| dense bodies | <cell biology> Areas of electron density associated with the thin filaments in smooth muscle cells. Some are associated with the plasma membrane, others are cytoplasmic. (12 Jan 1998) |
| dense-deposit disease | See: membranoproliferative glomerulonephritis. (05 Mar 2000) |
| dense liver | <radiology> Haemochromatosis, haemosiderosis, Wilson disease, Thorotrast, amiodarone, gold (for RA) (12 Dec 1998) |
| dense metaphyseal bands | <radiology> Normal variant, stress lines, heavy metal poisoning, treated rickets, scurvy, hypervitaminosis D (12 Dec 1998) |
| dense spleen | <radiology> Sickle cell disease, haemochromatosis, Thorotrast (12 Dec 1998) |
| large, dense breast lesions | <radiology> Carcinoma, sarcoma, cystosarcoma phylloides, cyst, abscess, lymph nodes (lymphoma, leukaemia, metastasis) (12 Dec 1998) |
| acquired platelet function defect | <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines). Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation. (29 Dec 1997) |
| antigens, human platelet | Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. (12 Dec 1998) |
| anti-platelet agents | Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| receptors, platelet-derived growth factor | Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. Pdgf binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain. (12 Dec 1998) |
| medication, anti-platelet | Platelet-blocking drugs. Drugs that, like aspirin, reduce the tendency of platelets in the blood to clump and clot. (12 Dec 1998) |
| platelet | <haematology> A discoid cell (3m diameter) found in large numbers in blood, important for blood coagulation and for haemostasis by repairing breaches (small breaks) in the walls of blood vessels. Platelet _ granules contain lysosomal enzymes, dense granules contain ADP (a potent platelet aggregating factor) and serotonin (a vasoactive amine). They also release platelet-derived growth factor which presumably contributes to later repair processes by stimulating fibroblast proliferation. Synonym: thrombocytes. (09 Oct 1997) |
| platelet-activating factor | <cytokine> Potent phospholipid activator and mediator of many leucocyte functions, including platelet aggregation, inflammation, and anaphylaxis. It is produced in response to specific stimuli by a variety of cell types, including neutrophils, basophils, platelets, and endothelial cells. Several molecular species of platelet-activating factor have been identified which vary in the length of the O-alkyl side chain. It is an important mediator of bronchoconstriction. Synonym: platelet-aggregating factor. Acronym: PAF (20 Sep 2002) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|